The following day, the patient was found to be hyperglycemic, with home FSBGs in the 500s.
We are asked to provide recommendation for management of patient's CHF.
Lower leg swelling has not changed over prior two months.
Past Medical History: DM A1c 7.9% [**2146-9-27**] 2VD s/p unsuccessful PCI mid-LAD [**2146-9-13**] Ischemic CMP EF 20-25% by TTE [**2146-9-11**] CKD stage III b/l Cr ~1.4 HTN Hyperlipidemia s/p bilat cataract surgeries  Cardiac Risk Factors include diabetes, dyslipidemia, hypertension, and family history of CAD   Social History: Patient is retired since [**2139**] from Met Life.
Physical Exam: Vitals: T: 97.9 BP: 98-100/68-74 P: 101-110 R: 20-24 O2: 100 on RA-2L General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP elevated to jawline, no LAD Lungs: decreased breath sounds at bases, crackles bilat L > R CV: Tachy rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, obese non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: no rashes, lesions   Pertinent Results: [**2146-11-3**] 10:00AM URINE  OSMOLAL-347 [**2146-11-3**] 10:00AM URINE  HOURS-RANDOM UREA N-376 CREAT-45 SODIUM-26 [**2146-11-3**] 12:00PM   PLT SMR-NORMAL PLT COUNT-285 [**2146-11-3**] 12:00PM   HYPOCHROM-NORMAL ANISOCYT-1+ POIKILOCY-NORMAL MACROCYT-NORMAL MICROCYT-1+ POLYCHROM-NORMAL [**2146-11-3**] 12:00PM   NEUTS-78.4* BANDS-0 LYMPHS-14.1* MONOS-6.3 EOS-0.8 BASOS-0.4 [**2146-11-3**] 12:00PM   CALCIUM-9.2 PHOSPHATE-2.9 MAGNESIUM-2.3 [**2146-11-3**] 12:00PM   CALCIUM-9.2 PHOSPHATE-2.9 MAGNESIUM-2.3 [**2146-11-3**] 12:00PM   GLUCOSE-479* UREA N-39* CREAT-1.8* SODIUM-121* POTASSIUM-7.2* CHLORIDE-85* TOTAL CO2-23 ANION GAP-20 [**2146-11-3**] 12:00PM   GLUCOSE-479* UREA N-39* CREAT-1.8* SODIUM-121* POTASSIUM-7.2* CHLORIDE-85* TOTAL CO2-23 ANION GAP-20  CXR: [**2146-11-3**] A moderate right pleural effusion is largely unchanged.
The end-diastolic pulmonic regurgitation velocity is increased suggesting pulmonary artery diastolic hypertension.
Brief Hospital Course: 67 F with DM, 2 vessel CAD, CKD, and ischemic cardiomyopathy (EF (20-25%) initially admitted with hyperglycemia after missing insulin for several days.
Transferred to the CCU for further management and started on lasix and milironone drip to optimize cardiac output.
CCU course complicated by the development of PEA requiring cardiac resuscitation with intubation and 4 pressor support.
A morphine drip was initiated and pressors and mechanical ventilation was discontinued.
Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Omeprazole 20 mg Capsule, Delayed Release(E.C.)
Lisinopril 2.5 mg Tablet Sig: One (1) Tablet PO once a day.
Lasix 80 mg Tablet Sig: One (1) Tablet PO twice a day.
Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).
Spironolactone 25 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily).
Insulin Glargine Insulin 4 units each morning (up titrate as needed) Humalog sliding scale.
[**Name10 (NameIs) **] evening dosing do not start additional insulin unless > 200. .
